World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Molecular Biology 102 496 444 275 242 383 38257
Biology and Biochemistry 111 937 831 584 508 462 44961

Stanley T. Crooke publications per year

The chart shows the history of publications by Stanley T. Crooke between 1951 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Stanley T. Crooke published across 75 years, from 1951 to 2025, averaging 6.9 papers a year. Output peaked at 35 publications in 1987. 11 of the 515 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1951 to 2025. Vertical axis: number of publications, 0 to 35. Peak 35 publications in 1987. 1951: 1 publication 1952: 0 publications 1953: 0 publications 1954: 0 publications 1955: 0 publications 1956: 0 publications 1957: 0 publications 1958: 0 publications 1959: 0 publications 1960: 0 publications 1961: 0 publications 1962: 0 publications 1963: 0 publications 1964: 0 publications 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 3 publications 1972: 3 publications 1973: 0 publications 1974: 0 publications 1975: 1 publication 1976: 3 publications 1977: 1 publication 1978: 10 publications 1979: 21 publications 1980: 17 publications 1981: 18 publications 1982: 15 publications 1983: 5 publications 1984: 11 publications 1985: 16 publications 1986: 30 publications 1987: 35 publications 1988: 27 publications 1989: 21 publications 1990: 14 publications 1991: 8 publications 1992: 5 publications 1993: 7 publications 1994: 7 publications 1995: 7 publications 1996: 12 publications 1997: 8 publications 1998: 12 publications 1999: 10 publications 2000: 9 publications 2001: 8 publications 2002: 1 publication 2003: 17 publications 2004: 8 publications 2005: 4 publications 2006: 2 publications 2007: 8 publications 2008: 1 publication 2009: 4 publications 2010: 1 publication 2011: 6 publications 2012: 5 publications 2013: 9 publications 2014: 5 publications 2015: 9 publications 2016: 13 publications 2017: 13 publications 2018: 8 publications 2019: 10 publications 2020: 11 publications 2021: 12 publications 2022: 7 publications 2023: 5 publications 2024: 4 publications 2025: 7 publications
1951 2025

515 publications in total across all disciplines

View publications per year as a table
Stanley T. Crooke: publications per year, 1951 to 2025
Year Publications
1951 1
1952 0
1953 0
1954 0
1955 0
1956 0
1957 0
1958 0
1959 0
1960 0
1961 0
1962 0
1963 0
1964 0
1965 0
1966 0
1967 0
1968 0
1969 0
1970 0
1971 3
1972 3
1973 0
1974 0
1975 1
1976 3
1977 1
1978 10
1979 21
1980 17
1981 18
1982 15
1983 5
1984 11
1985 16
1986 30
1987 35
1988 27
1989 21
1990 14
1991 8
1992 5
1993 7
1994 7
1995 7
1996 12
1997 8
1998 12
1999 10
2000 9
2001 8
2002 1
2003 17
2004 8
2005 4
2006 2
2007 8
2008 1
2009 4
2010 1
2011 6
2012 5
2013 9
2014 5
2015 9
2016 13
2017 13
2018 8
2019 10
2020 11
2021 12
2022 7
2023 5
2024 4
2025 7
Total 515
Download as CSV

Stanley T. Crooke publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Stanley T. Crooke sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 53 bars. Horizontal axis: publications, 47–56 to 564+. Vertical axis: number of scientists, 0 to 177. Most scientists, 177, have 117–126 publications. The last bar groups every scientist with 564 publications or more. The highlighted bar, 377–386 publications, is where this scientist sits. 47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47–56 publications 564+

This scientist: 383 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

View publications distribution as a table
Number of Molecular Biology scientists by publication count, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
Publications Scientists This scientist
47–56 7
57–66 17
67–76 65
77–86 90
87–96 125
97–106 131
107–116 162
117–126 177
127–136 158
137–146 158
147–156 146
157–166 159
167–176 131
177–186 110
187–196 112
197–206 100
207–216 89
217–226 98
227–236 74
237–246 72
247–256 63
257–266 53
267–276 54
277–286 49
287–296 52
297–306 43
307–316 46
317–326 41
327–336 42
337–346 31
347–356 28
357–366 29
367–376 26
377–386 24 383
387–396 24
397–406 14
407–416 13
417–426 20
427–436 12
437–446 20
447–456 11
457–466 10
467–476 14
477–486 14
487–496 10
497–506 13
507–516 13
517–526 2
527–536 4
537–546 6
547–556 8
557–563 6
564+ 100
Download as CSV

Stanley T. Crooke D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Stanley T. Crooke sits on this spectrum.

No. of scientists
25 50 75 100 125
Bar chart with 54 bars. Horizontal axis: D-Index, 40–41 to 145+. Vertical axis: number of scientists, 0 to 131. Most scientists, 131, have 64–65 D-Index. The last bar groups every scientist with 145 D-Index or more. The highlighted bar, 102–103 D-Index, is where this scientist sits. 40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40–41 D-Index 145+

This scientist: 102 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

View D-Index distribution as a table
Number of Molecular Biology scientists by D-index, Research.com 2026 ranking edition. Based on 3,076 ranked scientists.
D-Index Scientists This scientist
40–41 36
42–43 101
44–45 115
46–47 121
48–49 118
50–51 130
52–53 106
54–55 116
56–57 113
58–59 129
60–61 120
62–63 105
64–65 131
66–67 95
68–69 97
70–71 106
72–73 83
74–75 89
76–77 77
78–79 70
80–81 73
82–83 60
84–85 48
86–87 45
88–89 50
90–91 31
92–93 51
94–95 43
96–97 38
98–99 39
100–101 41
102–103 29 102
104–105 33
106–107 35
108–109 20
110–111 38
112–113 19
114–115 28
116–117 13
118–119 23
120–121 16
122–123 15
124–125 11
126–127 21
128–129 7
130–131 13
132–133 14
134–135 17
136–137 9
138–139 8
140–141 16
142–143 7
144 7
145+ 100
Download as CSV

Overview

Stanley T. Crooke is affiliated with Ionis Pharmaceuticals in the United States, where their research focuses primarily on biochemistry, genetics, and molecular biology. Their work encompasses various subfields including molecular biology, genetics, immunology, cell biology, and cancer research.

The research topics covered by Stanley T. Crooke include:

  • DNA and Nucleic Acid Chemistry
  • Advanced biosensing and bioanalysis techniques
  • RNA Interference and Gene Delivery
  • RNA Research and Splicing
  • CRISPR and Genetic Engineering
  • Genomics and Rare Diseases
  • Neurogenetic and Muscular Disorders Research

Stanley T. Crooke has contributed to multiple scientific publications, with several recent papers including the following:

  • Antisense technology: an overview and prospectus, 2021, Nature Reviews Drug Discovery
  • Phosphorothioate modified oligonucleotide-protein interactions, 2020, Nucleic Acids Research
  • Antisense technology: A review, 2021, Journal of Biological Chemistry
  • The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents, 2020, Journal of the American Chemical Society
  • Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides, 2021, Nucleic Acids Research

The venues where Stanley T. Crooke has frequently published research include:

  • Nucleic Acid Therapeutics
  • Nucleic Acids Research
  • Journal of the American Chemical Society
  • Nature Biotechnology
  • Nature Medicine

Stanley T. Crooke regularly collaborates with coauthors such as:

  • Xue-hai Liang
  • Timothy A. Vickers
  • Punit P. Seth
  • Cheryl Li De Hoyos
  • Lingdi Zhang

Best Publications

  • Antisense Research and Applications

    Sudhir Agrawal;Stanley T. Crooke

  • Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

    Frederick J Raal;Raul D Santos;Dirk J Blom;A David Marais

  • Therapeutic Applications of Oligonucleotides

    Stanley T. Crooke

  • Efficient Reduction of Target RNAs by Small Interfering RNA and RNase H-dependent Antisense Agents: A COMPARATIVE ANALYSIS *

    Timothy A. Vickers;Seongjoon Koo;C. Frank Bennett;Stanley T. Crooke

  • RNA-Targeted Therapeutics.

    Stanley T. Crooke;Joseph L. Witztum;C. Frank Bennett;Brenda F. Baker

  • Cisplatin : current status and new developments

    Archie W. Prestayko;Stanley T. Crooke;Stephen K. Carter

  • Antisense drug technology : principles, strategies, and applications

    Stanley T. Crooke

  • Progress in Antisense Technology

    Stanley T. Crooke

  • Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

    Nicholas J Viney;Julian C van Capelleveen;Richard S Geary;Shuting Xia

  • Oligoribonucleotides and ribonucleases for cleaving RNA

    Stanley T. Crooke

  • Mitomycin C: a review

    Stanley T. Crooke;William T. Bradner

  • Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II

    Fred H. Drake;Glenn A. Hofmann;Henry F. Bartus;Michael R. Mattern

  • Molecular mechanisms of action of antisense drugs.

    Stanley T Crooke

  • Oligoribonucleotides for cleaving RNA

    Stanley T. Crooke

  • Cisplatin (cis-diamminedichloroplatinum II).

    A.W. Prestayko;J.C. D'Aoust;B.F. Issell;S.T. Crooke

  • Cellular uptake and trafficking of antisense oligonucleotides

    Stanley T Crooke;Shiyu Wang;Timothy A Vickers;Wen Shen

  • Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant.

    Daniel Finley;Seth Sadis;Brett P. Monia;Paul Boucher

  • Progress in antisense oligonucleotide therapeutics.

    S T Crooke;C F Bennett

  • Antisense technology: an overview and prospectus

    Stanley T Crooke;Brenda F Baker;Rosanne M Crooke;Xue-Hai Liang

  • Basic Principles of Antisense Therapeutics

    S. T. Crooke

Frequent Co-Authors

David J. Ecker
David J. Ecker Ionis Pharmaceuticals (United States)
Eric E. Swayze
Eric E. Swayze Ionis Pharmaceuticals (United States)
Rosanne M. Crooke
Rosanne M. Crooke Ionis Pharmaceuticals (United States)
Richard S. Geary
Richard S. Geary Ionis Pharmaceuticals (United States)
Punit P. Seth
Punit P. Seth Ionis Pharmaceuticals (United States)
C. Frank Bennett
C. Frank Bennett Ionis Pharmaceuticals (United States)
Brett P. Monia
Brett P. Monia Ionis Pharmaceuticals (United States)
Lawrence B. Blyn
Lawrence B. Blyn Ionis Pharmaceuticals (United States)
Sotirios Tsimikas
Sotirios Tsimikas University of California, San Diego
Muthiah Manoharan
Muthiah Manoharan Alnylam Pharmaceuticals (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens the door to diverse career pathways that integrate scientific expertise with flexible online education. Many students now pursue healthcare professions through the best online pharmacy school programs, which are ideal for those seeking careers in pharmaceutical research or patient care.

If you are interested in human movement, wellness, or fitness, earning a fitness degrees online can help you become a trainer, coach, or exercise physiologist. Similarly, an online kinesiology degree provides foundational knowledge for roles in physical therapy, sports medicine, and rehabilitation.

For those drawn to mental health or advanced patient care, enrolling in the fastest pmhnp program offers a swift route to becoming a Psychiatric-Mental Health Nurse Practitioner. Whichever path you choose, online programs provide flexibility and accessibility, helping you align your studies with evolving career opportunities in the biological sciences.

Best Scientists Citing Stanley T. Crooke

Trending Scientists

Recently Published Articles